An observational study in Bone Density, Osteopenia and Amenorrhea, sponsored by Bagcilar Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 12 Years to 21 Years. Per ClinicalTrials.gov, last updated 2025-09-15.
Sponsored by Bagcilar Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 67 studies in Osteoporosis with a site in Turkey — 14 open to participants now, 17 under way, none of them phase 3. Osteoporosis · Turkey.
Among the 67 studies in Osteoporosis with a site in Turkey, this one is the 29th largest by enrollment of the 36 observational ones that give a count, is one of 11 that started in 2025, is one of 36 observational ones, and was the 51st registered.
1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.
Browse Osteoporosis studies →14 of the 67 studies in Osteoporosis with a site in Turkey are open now. Recruiting first, the newest first:
Kanuni Sultan Suleyman Training and Research Hospital · Sites in Turkey
Ages 45+ · Women only
Kanuni Sultan Suleyman Training and Research Hospital · Sites in Turkey
Ages 18+
Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Sites in Turkey
Ages 18+
Ankara Etlik City Hospital · Sites in Turkey
Ages 55–85 · Healthy volunteers
Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Sites in Turkey
Ages 18–65 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.
This study: 12 Years to 21 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
67 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 11 started in 2025.
This study's enrollment of 74 is below the median of 160 across 456 observational studies indexed under Osteoporosis.
Median enrollment 60 across the 31 interventional studies, 107 across the 36 observational. Of the 44 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 67 have an industry lead sponsor. The 10 most frequent:
Bagcilar Training and Research Hospital is the lead sponsor of 56 studies on the registry; 7 are open to participants now.
Bagcilar Training and Research Hospital has 2 studies filed under Osteoporosis — fewer than ten, so there is no comparison to draw.
4 of the studies in Osteoporosis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07228611Ankara Etlik City HospitalAssessment and Comparison of Osteoporosis Risk Factors After Stroke | 2026-12-01 |
| NCT07677072Kanuni Sultan Suleyman Training and Research HospitalCan Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women? | 2026-12-01 |
| NCT07486076Bartın UnıversityOSTEOPOROSIS EDUCATION AND ITS IMPACT ON OSTEOPOROSIS HEALTH BELIEFS AND AWARENESS IN WOMEN AT RISK OF OSTEOPOROSIS | 2027-01-20 |
| NCT07677033Kanuni Sultan Suleyman Training and Research HospitalFunctional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study | 2027-05-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 67 studies in Osteoporosis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This retrospective study evaluates bone mineral density (BMD) measurements obtained by dual-energy X-ray absorptiometry (DEXA) in adolescent girls aged 12 to 21 years at a tertiary care center. The study focuses on patients referred from the adolescent gynecology clinic as well as from other medical specialties.
Key objectives are:
Comparing the BMD indications and results requested from the gynecology department with the indications and BMD results requested from other departments. Thus, the BMD scores of patients with hypogonadism can be compared with other groups at risk for bone health.
To assess BMD Z-scores across specific gynecologic diagnoses, including premature ovarian insufficiency, functional hypothalamic amenorrhea (FHA), and hypogonadotropic hypogonadism.
To analyze the relationship between gynecologic clinical features-such as age at menarche and duration of amenorrhea-and BMD Z-scores.
By combining clinical, hormonal, and densitometric data, this study aims to identify risk factors for low bone density in adolescents, support earlier recognition of osteopenia/osteoporosis, and provide guidance for appropriate interventions in adolescent gynecology practice.
Adolescence is a critical period for bone mass acquisition, and disturbances during this stage may predispose to osteopenia or osteoporosis in later life. Various clinical conditions encountered in gynecology, endocrinology, and other specialties may require evaluation of bone mineral density (BMD). However, data on referral indications and bone health outcomes in adolescents remain scarce.
This retrospective study focuses on female adolescents aged 12-21 years who underwent dual-energy X-ray absorptiometry (DEXA) scans at a tertiary care center. The cohort includes patients referred from the adolescent gynecology clinic as well as those referred from other medical departments.
The study objectives are:
To compare referral indications for BMD testing between gynecology and other specialties.
To evaluate differences in BMD Z-scores across specific gynecologic diagnoses, including premature ovarian insufficiency (POI), functional hypothalamic amenorrhea (FHA), and hypogonadotropic hypogonadism.
To examine the relationship between clinical features (such as age at menarche and duration of amenorrhea) and BMD outcomes within the gynecology group.
The analysis will provide insight into how referral patterns, gynecologic and endocrine conditions, and clinical characteristics influence bone health in adolescent girls. By highlighting risk factors for low BMD, the study aims to support earlier recognition and management of bone health problems in this population.
1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.
This study's enrollment of 74 is below the median of 160 across 456 observational studies indexed under Osteoporosis.
Browse Osteoporosis studies →Bagcilar Training and Research Hospital is the lead sponsor of 56 studies on the registry; 7 are open to participants now.
Compared within Osteoporosis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Bone Diseases, Metabolic. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Female adolescents aged 12-21 years who underwent bone mineral density (BMD) measurement by dual-energy X-ray absorptiometry (DEXA) at a tertiary care hospital. The study includes patients referred from the adolescent gynecology clinic as well as those referred from other medical specialties (e.g., pediatrics, endocrinology).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients referred for DEXA scans due to gynecologic indications such as hypogonadism, amenorrhea, premature ovarian insufficiency \[POI\], functional hypothalamic amenorrhea \[FHA\], or hypogonadotropic hypogonadism
Patients referred for DEXA scans by other departments, such as pediatrics, endocrinology, or additional medical specialties
Bone Mineral Density (BMD) Z-scores in Adolescent Girls
Comparison of BMD Z-scores between adolescents (12-21 years) referred from the adolescent gynecology clinic and those referred from other specialties.
Time frame: At the time of DEXA scan (retrospective chart review, 2020-2025
Plan to share: No — No individual participant data (IPD) will be shared. The study is retrospective and based on medical records, and patient confidentiality restrictions prevent data sharing.
No publications or documents are linked to this record.
Ran from Jun 2025 to primary completion in Jun 2025, 0 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bagcilar Training and Research Hospital